Cellular Roles of DNA Polymerase Beta by Ray, Sreerupa et al.
University of New Haven
Digital Commons @ New Haven
Biology and Environmental Science Faculty
Publications Biology and Environmental Science
12-13-2013




University of Texas Health Science Center at Houston
Ali Senejani
University of New Haven, asenejani@newhaven.edu
Joann Balazs Sweasy
Yale University
Follow this and additional works at: http://digitalcommons.newhaven.edu/biology-facpubs
Part of the Biology Commons, and the Ecology and Evolutionary Biology Commons
Comments
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which
permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in
any way.
Publisher Citation
Ray S., Menezes M.R., Senejani A., Sweasy J.B. “Cellular Roles of DNA Polymerase Beta” Yale J Biol Med 2013 Dec 13;86(4):463-469
Yale Journal of Biology and Medicine
463
YAlE JOURNAl OF BiOlOGY AND MEDiCiNE 86 (2013), pp.463-469.
Copyright © 2013.
FOCUS: 50 YEARS OF DNA REPAiR: THE YAlE SYMPOSiUM
REPORTS
cellular roles of dnA Polymerase Beta 
Sreerupa Ray, Miriam Rose Menezes, Alireza Senejani, and Joann
B. Sweasy*
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut
Since its discovery and purification in 1971, DNA polymerase ß (Pol ß†) is one of the most
well-studied DNA polymerases. Pol ß is a key enzyme in the base excision repair (BER)
pathway that functions in gap filling DNA synthesis subsequent to the excision of damaged
DNA bases. A major focus of our studies is on the cellular roles of Pol ß. We have shown
that germline and tumor-associated variants of Pol ß catalyze aberrant BER that leads to ge-
nomic instability and cellular transformation. Our studies suggest that Pol ß is critical for the
maintenance of genomic stability and that it is a tumor suppressor. We have also shown
that Pol ß functions during Prophase i of meiosis. Pol ß localizes to the synaptonemal com-
plex and is critical for removal of the Spo11 complex from the 5’ ends of double-strand
breaks. Studies with Pol ß mutant mice are currently being undertaken to more clearly un-
derstand the function of Pol ß during meiosis. in this review, we will highlight our contribu-
tions from our studies of Pol ß germline and cancer-associated variants.
introduction
DNA polymerase beta (Pol ß) was
originally purified from rabbit bone mar-
row by Chang and Bollum and character-
ized as a low molecular weight DNA
polymerase [1]. Several years later, Abbotts
and Wilson subcloned the cDNA of both
human and rat Pol ß and successfully ex-
pressed this protein in Escherichia coli [2],
permitting large quantities of active en-
zyme to be purified and studied.
Pol ß is a 39 kDa protein with DNA
polymerase and deoxyribose phosphatase
(dRP lyase) activities [2-4]. It belongs to
the X family of DNA polymerases. DNA
polymerase β is expressed in all stages of
the cell cycle and in all of the analyzed tis-
sues [5,6]. Since the time of its cloning and
purification, Pol ß has become one of the
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most highly studied DNA polymerases. In
this overview, we will discuss our contribu-
tions to elucidating the mechanism of DNA
synthesis of Pol ß with particular regard to
variants of this enzyme identified in the
germlines of humans in tumors.
Joann Sweasy (JS) performed her grad-
uate work with Evelyn Witkin on the roles of
E. coli recA mutants in SOS mutagenesis
and the restart of DNA synthesis cultivated
an interest in the study of DNA polymerases
[7-9]. This led her to join Lawrence Loeb’s
laboratory, where she began research on Pol
ß. To understand the mechanisms of sub-
strate choice by Pol ß, JS set out to charac-
terize mutator variants of Pol ß.
Identification of mutator variants in human
or mouse cells would be difficult, so, draw-
ing upon her previous experience as a grad-
uate student, she decided to develop a
complementation system in E. coli, and,
using the Pol ß cDNA clone generously
given to the laboratory by Dr. Samuel Wil-
son, showed that rat Pol ß could substitute
for E. coli Pol I in the joining of Okazaki
fragments during DNA replication [10]. This
permitted JS to use E. coli mutation re-
porters to identify Pol ß mutator mutants
[11]. JS carried a box full of Pol ß mutator
variants [12] with her to her new faculty po-
sition in the Department of Therapeutic Ra-
diology at Yale School of Medicine, a
department with an incredible history of re-
search in DNA repair that she was very en-
thusiastic to join. Since that time, JS’s
laboratory has characterized many of these
mutator variants of Pol ß, showing how
amino acid residues of Pol ß distant from the
active site are critical for accurate DNA syn-
thesis. In addition to this work, JS became
interested in understanding the cellular roles
of Pol ß and initiated work in this area using
polymorphic and cancer-associated variants
of Pol ß, and this is the focus of this
overview. 
Pol ß And BAse excision rePAir
Pol ß functions in base excision repair
(BER), a major genome maintenance path-
way in mammalian cells that is responsible
for removal and repair of at least 20,000
DNA lesions per cell per day [13]. The sim-
plest and most common form of BER is
short patch BER, which can be initiated by
one of several different DNA glycosylases,
each having preferences for specific types of
lesions [14]. Monofunctional DNA glycosy-
lases recognize DNA lesions and catalyze
the hydrolysis of the N-glycosylic bond to
generate an abasic site. The abasic site is
nicked at its 5’ side by the APE1 endonucle-
ase, leaving a 3’OH and a 5’deoxyribose
phosphate (dRP). Pol ß fills in the single nu-
cleotide gap and catalyzes removal of the
dRP group. Bifunctional glycosylases,
which usually recognize oxidative lesions,
generate an abasic site and then catalyze its
removal via ß-elimination to generate a
3’dRP and 5’phosphate. APE1 then removes
the 3’dRP, leaving a 3’OH, to which Pol ß
can bind and fill in the resulting single nu-
cleotide gap. In both cases, the XRCC1/Lig-
ase IIIα or XRCC1/Ligase I complex
catalyzes ligation of the resulting ends. An
alternative BER pathway that does not de-
pend on APE1 is utilized when the NEIL
glycosylases initiate repair [15]. NEIL 1, 2,
and perhaps 3 catalyze excision of the dam-
aged base via ß,δ elimination, leaving a
3’phosphate and a 5’phosphate. The 3’phos-
phate is removed by polynucleotide kinase,
leaving a gap that is most often filled by Pol
ß, followed by ligation. Therefore, Pol ß is
required for all forms of BER.
Germline VAriAnts of Pol ß
Five hundred sixty-seven SNPs have
been identified in the 33 Mb POLB gene, of
which only 22 are found within the coding
region [16,17]. Two missense germline vari-
ants of Pol β have been identified in the
human population. These are R137Q
(rs12678588) and P242R (rs3136797),
which have been reported to be present in 0.6
percent and 2.4 percent, respectively, of the
human population [18]. The P242R variant
was specifically identified in Keralites and
Europeans. The R137Q Pol ß variant has re-
duced polymerase activity and an impaired
interaction with PCNA. When expressed in
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Pol β-deficient MEFs, R137Q confers sensi-
tivity to the DNA damaging agents methyl
methanesulfonate (MMS) and N-methyl-N-
nitrosourea (MNU) [19]. Pol β P242R also
catalyzes DNA synthesis with a reduced rate
[20]. In human mammary epithelial cells,
P242R Pol β induces chromosomal aberra-
tions and cellular transformation, suggesting
a putative role for P242R Pol β as a cancer
driver [20]. The mechanistic basis underly-
ing the generation of chromosomal aberra-
tions is the slow BER gap filling catalyzed
by P242R. Unfilled gaps in the proximity of
the replication fork lead to the induction of
double-strand breaks and can result in chro-
mosomal aberrations, as shown in Figure 1.
The studies on Pol β R137Q and P242R sug-
gest that individuals with these variants have
an increased risk of developing cancer. This
hypothesis is currently being tested using
mouse models. 
tumor-AssociAted Pol ß VAriAnts
Small-scale sequencing studies have re-
vealed that POL B is mutated in 30 percent
to 40 percent of human tumors, including
colon, gastric, and prostate carcinomas
[21,22]. Interestingly, the resulting amino
acid alterations are not localized to one par-
ticular domain of Pol β but are widespread
across the protein [22].
Colon Tumor-Associated Pol ß Variants
The K289M Pol ß variant was identified
in a colon carcinoma [23]. We showed that
K289M is a sequence context-dependent
mutator in mouse cells and that it induced
mutations at a 16-fold greater frequency
within a sequence nearly identical to a highly
mutated sequence in the APC gene, the mu-
tation of which results in colon cancer [24].
Work from our laboratory also demonstrated
that expression of K289M in immortal but
non-transformed mouse cells induces cellu-
lar transformation through a mutational
process as shown in Figure 1 [25]. 
Given this result, our laboratory se-
quenced the exons 5’ and 3’ UTRs of the
POL B gene from colon tumors and found
that 40 percent of these tumors carried a mu-
tation in the coding region of POL B that
was not found in normal tissue [22]. A sub-
set of these variants that were predicted by
mathematical algorithms to be damaging ex-
hibited reduced DNA polymerase activity.
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figure 1. mechanisms of genomic instability generated by Pol ß variant proteins.
The DNA substrate for Pol ß is usually a single nucleotide gap with a 5’dRP group (red)
that is generated upon excision of a damaged base. A mutator variant of Pol ß will remove
the dRp group using its dRp lyase activity and fill in the gap in an error-prone manner, in-
ducing mutations (denoted by X). A Pol ß variant with slow polymerase activity (low activity
variant) will remove the dRp group, but not fill in all gaps in the cell, leading to the accu-
mulation of BER intermediates and eventually to genomic instability. Failure to remove the
dRp group by a Pol ß variant with slow dRp lyase activity will also result in the accumula-
tion of BER intermediates and genomic instability.
We showed that two of these variants,
G231D and E295K, which was also identi-
fied in a gastric carcinoma [26], induce
chromosomal aberrations and cellular trans-
formation [27,28]. The G231D variant has a
low affinity for the incoming nucleotide due
to a disordered active site once bound to
DNA [27]. E295K appears to lack DNA
polymerase activity as a result of its inabil-
ity to assume an active polymerase confor-
mation [28,29]. During BER, neither of
these variants fills single nucleotide gaps in
an efficient manner, leading to the accumu-
lation of BER intermediates and resulting in
an increase in double-strand breaks and ge-
nomic instability (Figure 1). The E288K
variant was also identified in a colon carci-
noma [22]. Interestingly, this variant is a se-
quence context-dependent mutator and
prefers to misincorporate nucleotides oppo-
site template A, which could result in a mu-
tator phenotype in human cells [30].
Gastric Carcinoma-Associated Pol ß
Variants
In addition to E295K, Pol β L22P,
Y265C, and D160N were identified in
human gastric carcinomas [26]. L22P has
low affinity for DNA and very low dRP
lyase activity [31]. The expression of L22P
in Pol β deficient mouse embryo fibroblasts
(MEFs) results in sensitivity to MMS and
cellular transformation in immortalized
mouse cells, likely as a result of the accu-
mulation of BER intermediates [31]. Y265C
catalyzes DNA synthesis at a significantly
slower rate than WT Pol ß and is also a mu-
tator polymerase [11,32,33]. In mouse LN12
cells, expression of Y265C leads to an 8-fold
increase in mutation frequency, and the
types of mutations induced include point
mutations and small deletions [32]. Y265C
has normal dRP lyase activity [34]. We re-
cently constructed the Y265C Pol β knock-
in mouse model [34]. The homozygous
mutant animals are born at the expected
Mendelian ratio; however, they are small
and 60 percent die within a few hours post
birth. The POL B Y265c/c E11 and E14 em-
bryos and newborn mice are 33 percent
smaller (p < 0.0001) than their wild-type and
heterozygous littermates [34]. We showed
that MEFs isolated from these mice exhibit
slow proliferation. Significantly higher lev-
els of apoptosis were observed in the POL B
Y265c/c MEFs versus MEFs from wild-type
mice. In combination, these results indicate
that both slow proliferation and increased
cell death contribute to the small size of the
c/c mice [34]. We showed that BER inter-
mediate substrates accumulate in the POL B
Y265c/c MEFs in the form of unfilled gaps and
that these substrates resulted in increased
levels of chromosomal aberrations. The
D160N variant, also identified in a gastric
carcinoma, induces complex tandem muta-
tions that appear to be template-dependent
[35]. We suggest that the active site of this
variant exists in a conformation that can ac-
commodate movement of the DNA sub-
strate, permitting complex mutations to be
generated.
Prostate Cancer-Associated Pol ß Variant
The I260M prostate cancer-associated
variant is a sequence context-dependent base
substitution mutator [36] that also induces in-
sertions of dinucleotide repeats within runs
of the same types of repeats. Expression of
I260M in immortal but non-transformed
mouse epithelial cells results in cellular
transformation by a mutational mechanism
[25] (Figure 1, mutator phenotype).
In summary, Pol ß variants have the po-
tential to drive cancer by induction of a mu-
tator phenotype or genomic instability, as
shown in Figure 1. Our results suggest that
during the gap filling step of BER, which
occurs at least 20,000 times per cell per day,
some of the Pol ß variants, including I260M,
insert the incorrect nucleotide, eventually re-
sulting in a mutation. Should the mutation
occur within key growth control genes, it
could lead to cancer. For example, we
showed that expression of I260M in mouse
epithelial cells led to mutation of PPARγ, re-
sulting in global alterations in gene expres-
sion [37]. Interestingly, PPARγ has been
suggested to function as a tumor suppressor.
In contrast, many of the Pol ß variants fill
single nucleotide gaps less efficiently than
WT Pol ß, leading to accumulation of BER
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intermediates that result in chromosomal
aberrations and cellular transformation.
BER is a highly coordinated process, and
our results suggest that imbalances in this re-
pair pathway have the potential to lead to
cancer. In combination, our results suggest
that Pol β is critical for the repair of en-
dogenous DNA damage and the mainte-
nance of genomic stability.
role of dnA PolymerAse β in
meiosis
Meiosis involves a highly orchestrated
process of cell division wherein diploid cells
undergo two successive divisions to produce
four haploid germ cells. Meiotic recombina-
tion involves physical interaction between
homologous chromosomes, which form chi-
asmata and lead to crossover products [38].
The meiotic recombination pathway is in-
duced by formation of DNA double strand
breaks (DSBs) by the meiosis-specific
Spo11 complex, a relative of archeal topoi-
somerase VI [39], during the leptotene sub-
stage of Prophase I [40]. DSBs are marked
by formation of γH2AX foci, a phosphory-
lated version of H2A. DSBs are repaired
through the pachytene substage of Prophase
I in processes resulting in crossover and
non-crossover products [39]. Synapsis oc-
curs between chromosomes and genetic ex-
change is facilitated by synaptonemal
complex (SC) formation. Upon introduction
of DSBs, Rad51, a RecA homolog in eu-
karyotes promotes homology search and
DNA strand invasion. Dmc1, a meiosis-spe-
cific protein, also promotes homology-di-
rected DNA strand exchange that leads to
crossover products. The homologs synapse
in the zygotene substage of Prophase I [41].
During the diplotene substage, the homologs
desynapse and crossovers are formed which
are an essential outcome of meiotic recom-
bination [41]. The crossovers are observed
as chiasmata [42,43]. The enzymes involved
in the catalysis of DNA synthesis during
meiosis are not well characterized.
DNA polymerases are known to function
in DNA replication, repair, and recombina-
tion. Interestingly, expression of DNA Pol β
is highest in mouse testis, suggesting that it
may have a role in meiosis [44]. Recently it
has also been shown that overexpression of
Pol β stimulates Rad51-dependent homolo-
gous recombination in mammalian cells [45].  
We initiated our studies of Pol ß in
meiosis in collaboration with Terry Ashley
and attempted to localize Pol ß to the SC.
We showed that Pol ß foci were present on
the SC during Prophase I of meiosis in a pat-
tern consistent with the idea that this enzyme
functions in DSB repair during this process
[44]. Deletion of the POL B gene in mice
leads to lethality, thus to characterize the
role of Pol β in meiosis, we employed the
Cre-loxP gene targeting system to delete the
POL B gene specifically in primordial germ
cells. Synapsis is defective in spermatocytes
and oocytes isolated from these mice. Im-
portantly, Pol β-deficient spermatocytes
have persistent Spo11-induced γH2AX
DSBs and a significantly reduced level of
Spo11-complex removal from the 5’ end of
the DSB. Thus Pol β has a very critical role
in meiosis that is associated with the re-
moval of the Spo 11 complex [41]. We sug-
gest that Pol ß can act as a “landing
platform” for other proteins that are required
for Spo 11 removal. Alternatively, Pol ß
could facilitate formation of a DNA struc-
ture, which is conducive to removal of
Spo11. Additional experiments are being
conducted to more clearly define the role of
the Pol ß protein in Prophase I of meiosis.
conclusions And outlook
Experiments from our laboratory have
shown that Pol ß functions in DNA repair
and during Prophase I of meiosis. Pol ß
functions to maintain genomic stability dur-
ing DNA BER. Both germline and cancer-
associated variants lead to aberrant DNA
repair that is either error-prone or inefficient,
resulting in the accumulation of BER inter-
mediates. Therefore, Pol ß somatic and
germline variants have the potential to be
cancer drivers and to impact cancer therapy.
We have also shown that Pol ß functions
during Prophase I of meiosis, although its
precise role during this process is not
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known. This has led us to characterize meio-
sis in mice that express various Pol ß vari-
ants and these experiments are currently
under way. 
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